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Participation in research bronchoscopy:
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Bronchoscopy is the preferred method for collecting biological samples from the lower airways of subjects in
clinical research. However, ensuring participation in clinical research can be challenging when the research
includes an invasive procedure. For this report we reviewed the literature to look for information on
participation in research bronchoscopy studies to better design our own study, the Bergen COPD Microbiome
study (MicroCOPD). We performed a systematic literature search on participation in research bronchoscopy
studies in February 2014 using the search engines of PubMed and EMBASE. The literature search resulted in
seven relevant papers. Motivation was an end point in six of the seven papers, but reasons for declining
participation and recruitment strategies also seemed important. Human subjects participate in research
bronchoscopy studies for personal benefit and altruistic reasons. Inconvenience associated with research, in
addition to fear of procedures, is considered a barrier. Radio, especially news stations, generated the most
inquiries for a clinical study involving bronchoscopy. There is a lack of information on participation in
research bronchoscopy studies in the literature. A bronchoscopy study has been initiated at Haukeland
University Hospital, Bergen, Norway, to examine the role of the microbiome in COPD, and participation will
be explored as a substudy.
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C
hronic obstructive pulmonary disease (COPD)
will be the third leading cause of death in 2030,
according to estimates by the World Health
Organization (1). The mechanisms explaining why only a
limited fraction of individuals exposed to tobacco and
other air pollutants develop COPD remain unknown.
Recent advances in the field of metagenomics have indi-
cated that airway microbiota might differ between subjects
with and without COPD (2). To sample the airway micro-
biota, it is necessary to have a feasible method, yet with
minimal contamination. Although induced sputum is a
possibility (3), this method is prone to contamination from
the oral microbiota. Furthermore, the accuracy in pre-
dicting which segments of the airways are being sampled
is uncertain.
Bronchoscopy is a safe procedure with a low complica-
tion rate (4) and is the ideal procedure both to ensure
minimal contamination as well as to enable mapping of
different areas of the airways. However, a semi-invasive
procedure such as bronchoscopy can be associated with
discomfort. Together with pre-procedural anxiety, this dis-
comfort might lower participation in studies that sample
the airways by bronchoscopy. Previous studies on the
airway microbiota in asthma and COPD patients with
bronchoscopic sampling had low numbers of participants
(2, 5, 6). There is a need for studies with more statis-
tical strength to secure reliable and reproducible data.
However, large-scale bronchoscopy studies would require
attention to logistic challenges, including recruitment and
participation.
The views expressed in this report are that of the authors and not the official position of the institution.
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More information on response rates and participa-
tion motives could lead to better-targeted recruitment for
clinical studies. Furthermore, by revealing common pre-
procedural concerns and anxieties, it might be possible
to also improve patient information and compliance in
regular clinical practice. The aim of the current report
was to perform a systematic review of the current litera-
ture on participation motives, response rates, and recruit-
ment strategies in research bronchoscopy studies with an
emphasis on studies including COPD patients.
Methods
Search strategy
Two separate literature searches were performed using
the PubMed search engine of the US National Library
of Medicine (7) and the Excerpta Medica Database
(EMBASE) provided by the medical publisher Elsevier (8).
PubMed papers are indexed by keywords called medical
subject headings (MeSH) (9). Due to the hierarchical
organization, generalized MeSH terms include papers
classified by specific MeSH term. We identified MeSH
terms from the indexed papers in initial searches, supplied
by qualified suggestions from a collegial brainstorming
session using a modification of a populationintervention
comparisonoutcome (PICO) scheme (10). Most search
terms were included as both MeSH terms and text words
to increase search sensitivity. The columns were combined
with ‘OR’, and rows were combined with ‘AND’.
EMBASE has similar functions as PubMed, though
MeSH terms are replaced by Emtree terms. We used the
same modified PICO scheme (Table 1) for the EMBASE
search. MeSH terms were replaced by explosion search,
and text words were replaced by multipurpose (mp) terms.
Titles and abstracts were sifted and classified by pres-
pecified exclusion and inclusion criteria (Table 2). Only
papers concerning recruitment to studies including bron-
choscopy were included. Reports of motives or perceived
benefits of participation in studies with respiratory inva-
sive procedures, reasons for non-response, recruitment
sources, and response rates in studies involving respiratory
invasive procedures were included. Papers not written
in English or a Scandinavian language were excluded,
together with non-human studies, case studies, and secon-
dary publications, including literature reviews, reports, com-
ments, letters, guidelines, newspaper articles, books, or
book chapters. Studies that did not have participation as a
main objective or as a study end point were also excluded.
Similar criteria were used in evaluating retrieved papers
found from both the PubMed and EMBASE searches.
Table 1. Modified PICO scheme used for a literature review on participation in research bronchoscopy studies
P1 P2 I O
COPD (MeSH) Patients (MeSH) Bronchoscopy (MeSH) Patient participation (MeSH)
COPD (tw) Patients (tw) Bronchoscopy (tw) Participation (tw)
Chronic obstructive
pulmonary disease (tw)
Participants (tw) Response (tw)
Human volunteers (MeSH) Non-response (tw)
Volunteers (tw) Attitude (MeSH)
Study (MeSH major topic) Attitude (tw)
Trial (MeSH major topic) Motivation (MeSH)
Research subjects (MeSH) Motivation (tw)
Research subjects/psychology (MeSH) Refusal to participate (MeSH)
Clinical research (MeSH) Refusal to participate (tw)
Informed consent (MeSH)











The P1 column was excluded in the final search due to a paucity of results.
P, population; I, intervention; C, comparison; O, outcomes; MeSH, medical subject headings; tw, text words
Einar Marius Hjellestad Martinsen et al.
2
(page number not for citation purpose)
Citation: European Clinical Respiratory Journal 2016, 3: 29511 - http://dx.doi.org/10.3402/ecrj.v3.29511
Results
Results from the two literature searches were classified
as shown in Table 2. The majority of papers, 1,117, were
excluded due to their lack of participation as a main
objective or study end point. The PubMed search yielded
eight relevant papers, and the EMBASE search yielded
nine relevant papers. Seven out of nine articles from the
EMBASE search were also found in the PubMed search.
Thus, 10 individual papers were included for in-depth
review. Three of these 10 papers did not report participa-
tion and were excluded.
Table 3 provides an in-depth overview of the final seven
included papers (1117). Four of the papers were pub-
lished in the last five years, and six of the studies were
conducted in Europe. Six papers focused on motives or
perceived benefits of participation for studies involving
research bronchoscopies (11, 12, 1417). One of these
also reported reasons to decline participation (16), and
one studied predictors for the decision to consent to a
second bronchoscopy (14). Further, one study evaluated
the recruitment process in a lung cancer chemopreven-
tion study that included a research bronchoscopy (13).
Research bronchoscopies were carried out in all the
studies (Table 3).
Five of the reviewed studies were prospective (11, 1316).
The largest included 146 participants in a smoking cessa-
tion trial (17), whereas the smallest examined 18 subjects
(12). Three studies were limited to current or ex-smokers as
study subjects (13, 16, 17), and none of these studies
compared results with a healthy control population.
Only one study included COPD patients (16), but the
study emphasized lung cancer. Thus, none of the studies
published results generalizable to a COPD population.
The most frequently used method of obtaining infor-
mation was interviews (12, 13, 1517), which were con-
ducted by telephone in three of the studies (12, 13, 17).
The remaining two studies made use of self-completed
questionnaires for data collection (11, 14). Statistical
methods were not reported in three of the included
studies (1113). The effects of demographic variables on
participation were examined in five of the papers (1317).
Motivation and benefits of study participation
We identified four main groups of motives for par-
ticipation in bronchoscopy studies  personal benefit
(11, 12, 1417), altruism (11, 14, 16), perceived importance
of research (11, 12), and obedience to the authority of the
researchers (14).
Personal benefit was found as a participation motive
in all six papers that examined participation motives
(11, 12, 1417). The benefits appeared to take various
forms, but were mainly defined as interest in their own
health (11, 14, 17), getting a proper health assessment
(15, 16), or treatment or surveillance of their health (12, 15).
In the study of parents of children with cystic fibrosis
(CF), personal benefit was more important when they
accepted participation on behalf of their children com-
pared to parents of healthy control infants (98 vs 25%)
(11). In the Malawian study, new volunteers expected
participation to be of benefit to them, perceived as health
assessment and prompt treatment (15). In the study on
an HIV-infected population in the United Kingdom, two-
thirds of participants stated personal benefit as impor-
tant, but only 51% gave their own health as their main
motive for participation (14).
In the latter study (14), altruism was considered the
main reason for participation by HIV-infected patients.
The same was true for parents of healthy controls in
the CF casecontrol study (11). In the study by Patel
et al., four of seven elderly participants (age 70) gave
altruistic reasons for participation. However, this motive
was often accompanied by self-interest. No participants
stated altruism as the only motive for participation (16).
Participation as a result of physician’s authority was
rare, but could be seen in the study by Lipman et al. (14),
which found that participants were motivated by being
asked by a physician or that the physician seemed to
want them to participate. Kerrison et al. (12) found a
Table 2. Number of retrieved papers for a literature search in the databases PubMed and EMBASE on participation in research
bronchoscopy studies according to classification criteria
Classification criteria PubMed EMBASE
Total number retrieved 989 987
Non-English/non-Scandinavian language 102 None
Case studies/series 82 427
Secondary publications 116 108
Non-human studies 7 None
Participation not a major topic 674 443
Papers included in review 8 9
Papers common to PubMed and EMBASE searches 7
Secondary publications included reviews, expert panels, letters, guidelines, and so on. The EMBASE search excluded studies in
languages other than English and Scandinavian languages, as well as non-human studies
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somewhat similar motive when participants described
their participation as an important investment in scientific
progress. This motive was also mentioned by 32% of the
parents in the CF casecontrol study (11).
Response rates
Response rate, defined as number of enrolled divided by
approached or prescreened individuals, was a main objec-
tive in three of the reviewed papers (11, 13, 14), whereas
response rates could be found or derived from two
additional papers (12, 17). Response rates varied from
3 to 73% (11, 17) and seemed to be higher in studies
involving individuals that were affected by the index
disease (11, 14). Chudleigh et al. showed that recruitment
of healthy controls was feasible, but more challenging
than recruiting CF patients (11). Only Lipman et al.
looked into predictors for participation and found that
participants were significantly older (14).
Refusal
Reasons for declining primary participation or a second
bronchoscopy was reported in three articles (13, 14, 16),
and disadvantages of participation were examined in one
study (11). All studies exploring refusal to participate listed
a negative view on bronchoscopy as a main reason for non-
response (13, 14, 16), and the severity and duration of
previous experienced post-bronchoscopy symptoms was
the most common reason to refuse a second research
bronchoscopy in an HIV population (14). Patients that
refused or were unsure (21% of participants who already
had undergone a bronchoscopy) had more clinically
advanced HIV infection. However, all of the participants
did agree to a second bronchoscopy if medically indicated
(14). Patel et al. identified barriers to participation as
disadvantages of involvement exemplified by travel incon-
venience, bad experiences, and negative perceptions of
bronchoscopy (16), whereas Chudleigh reported anxiety
and perceived risk for complications as negative aspects of
participation (11).
Recruitment strategies
The study by Kye et al. was the only one reporting the
efficacy of various recruitment strategies, and in a US
lung cancer screening trial they found that radio adver-
tisement was the most effective, especially information
on the news stations, followed by Internet posting, print
media, posted and racked flyers, and mass mailings (13).
Discussion
We have shown that the literature on participation in
research bronchoscopy studies is somewhat limited.
Nevertheless, investigators planning new studies might
benefit from some inferences. First, it seems that both
control subjects and younger individuals have lower
response rates (11, 14). The highest response rates were
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and in a study of an HIV population (14). Conversely,
healthy subjects in a chemoprevention study had the
lowest participation rate (3.1%) (13), possibly suggesting
that more advanced diseases result in higher participation
fractions. However, the latter study also pointed out the
challenge of recruiting healthy subjects, as these require
strict entry criteria and minimal comorbidities, which
may also have contributed to their very low response rate.
An earlier review conducted on participation in COPD
studies without an invasive procedure also examined res-
ponse rates (18). Sohanpal et al. found that study parti-
cipation rates were higher than expected, and 81% of the
studies included had a study participation rate above
50%. This finding conforms to the current report. The
average participation rate was 77.8% in Sohanpal et al.’s
review, whereas our review had an average of 55.8%,
possibly suggesting higher participation rates in studies
without invasive procedures. However, our material is
limited and caution needs to be taken when comparing
these results. Second, it seems that the main motivation
for participation lies somewhere in a balance between
perceived personal health benefit and altruism. This war-
rants some caution from investigators in not portraying
participation as a substitution for otherwise inadequate
healthcare access and some modesty in what results
might be expected from the study. In particular, profes-
sionals should be aware that perceived authority results
in undue pressure on invitees (14). Third, the main reason
for non-response or declination of participation was fear
related to the invasive procedure. It would be logical
to assume that both content and deliverance of study
information influences participation, but no study exam-
ined these factors in detail. Fourth, participation in
research bronchoscopy does not seem to negatively in-
fluence patient consent for medically indicated proce-
dures (14), which is of key importance when deciding
whether or not to include bronchoscopy in a clinical
study. Finally, researchers considering media as a recruit-
ment source should know that radio and Internet
advertising seem to be the most effective sources (13).
The distinction between non-therapeutic and therapeu-
tic studies could possibly give rise to different participa-
tion motives. In the current review, we defined three of
the articles as therapeutic (13, 16, 17), defined by any
perceived direct benefit to the participants involved, and
four as non-therapeutic (11, 12, 14, 15). Interestingly, all
six papers that focused on motivation (11, 12, 1417)
reported personal benefit to be important. The perceived
benefit from a non-therapeutic study could reflect a lack
of understanding among the participants, thus emphasiz-
ing the importance of providing adequate and detailed
information to eligible subjects.
In comparison to our area of study, participation
in colorectal cancer screening trials was reviewed by
Bakker et al. (19). They found that participation rates
and completion of the fecal occult blood test as a screen-
ing procedure was higher when the researcher added the
screening kit to the invitations. The addition was com-
pared to invitations in which participants had to request
the kit if interested or visit their general practitioner or a
screening center to obtain the kit. In addition, a higher
test completion rate was observed if participants received
the test by post before a health check rather than being
offered the test at the health check. General practitioner
involvement and face-to-face invitation also resulted in
higher participation. Furthermore, long travel distances
from the screening facility were considered a participa-
tion barrier, consistent with results reported in the study
by Patel et al. included in the current review (16).
A review by Ellis assessed patient and physician
participation in randomized clinical trials in oncology
(20). In line with our findings, the review confirmed that
altruism, personal benefit, and scientific contribution
were important motives for participants. Physician’s
authority was not emphasized, but patients that trusted
their doctors seemed more willing to participate in clinical
trials. Males, older patients, less well-educated persons
or persons from lower socioeconomic backgrounds were
also more inclined to participate. Among the reasons for
non-response the authors emphasized fear of randomi-
zation, suggesting the process to be unfair, and loss of
freedom to make their own decisions. Some individuals
reported the feeling of being a guinea pig as unpleasant.
Lack of information and distrust of the medical profession
also appeared as barriers. Further, large difference in the
treatment offered negatively influenced the decision to
participate.
Our review has also revealed some limitations in the
existing literature and some fields that warrant further
research. The bulk of literature was on participation
motives, whereas only two studies presented information
on non-responders. Only one of these two presented a res-
ponse rate, but this study had fewer than 100 individuals
in their final analysis, and only 52% of the participants
had actually undergone a bronchoscopy at the time of
analysis (14).
We have summarized the existing literature on recruit-
ment strategies, response rates, and participation motives
in studies including bronchoscopy as a part of their design.
In particular we set out to identify studies including
COPD patients, but found there was very little data on
this patient group. Inclusion for an observational bron-
choscopy study was completed in June 2015 at Haukeland
University Hospital, Bergen, Norway (MicroCOPD).
The aim of the MicroCOPD study is to shed light on
the role of the microbiome in COPD (21). Participants
underwent a bronchoscopy with collection of protected
specimen brushes, small-volume lavage, bronchoalveolar
lavage, and bronchial biopsies. The respiratory microbiome
in subjects with and without COPD will be investigated
Einar Marius Hjellestad Martinsen et al.
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relative to disease progression and development and are
expected to provide insight in a new and promising re-
search field. Participation will be examined as a substudy.
Motives for participation will be asked as an open ques-
tion before the bronchoscopy. Response rates will be
estimated, and predictors for participation are targeted
to be revealed. It is anticipated that these results will
contribute to later research on COPD and facilitate the
conduction of other bronchoscopy studies.
Conclusions
A literature search performed between December 2013 and
February 2014 exploring participation in clinical studies
involving research bronchoscopies yielded seven relevant
articles. Conducting bronchoscopy studies involves diffi-
culties in recruiting control subjects and younger indi-
viduals, as well as the invasive nature of the procedure.
Responders seem driven by a combination of personal
health benefit and altruistic motives. However, we found
no solid evidence on recruitment for COPD studies, and
the characterization of non-responders had major limita-
tions. Thus, further research on participation in broncho-
scopy studies is warranted.
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